GRK6 and myeloid sarcoma: Similarly, significant downregulation of GRK2 and GRK6 expression has been observed in peripheral blood mononuclear cells (PBMCs) from patients with rheumatoid arthritis (RA) or multiple sclerosis (MS)52–54.